Deepa Rangachari

Deepa Rangachari

UNVERIFIED PROFILE

Are you Deepa Rangachari?   Register this Author

Register author
Deepa Rangachari

Deepa Rangachari

Publications by authors named "Deepa Rangachari"

Are you Deepa Rangachari?   Register this Author

44Publications

880Reads

29Profile Views

Extensive-Stage Small-Cell Lung Cancer With Sustained Complete Response to Single-Agent Nivolumab and Immune-Related Dermatitis.

Clin Lung Cancer 2020 Jan 26;21(1):e6-e9. Epub 2019 Sep 26.

Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2019.09.005DOI Listing
January 2020

From Hope to Reality: Durable Overall Survival With Immune Checkpoint Inhibitors for Advanced Lung Cancer.

J Clin Oncol 2019 Oct 2;37(28):2511-2513. Epub 2019 Jun 2.

Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.01207DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879313PMC
October 2019

Twelve tips for teaching oncology to non-oncologists.

Med Teach 2019 Oct 30:1-6. Epub 2019 Oct 30.

Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0142159X.2019.1682534DOI Listing
October 2019

Can PD-L1 tumor proportion score be used as the key to unlocking the KEYNOTE studies of pembrolizumab in advanced lung cancer?

Transl Lung Cancer Res 2019 Oct;8(5):715-722

Department of Medicine, Division of Medical Oncology, Beth Israel Deaconess Medical Center (a member of Beth Israel Lahey Health), Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2019.05.12DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835108PMC
October 2019

When Should Tumor Genomic Profiling Prompt Consideration of Germline Testing?

J Oncol Pract 2019 Sep;15(9):465-473

Beth Israel Deaconess Medical Center, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.19.00201DOI Listing
September 2019

Radiologic and autopsy findings in a case of fatal immune checkpoint inhibitor-associated pneumonitis.

Cancer Treat Res Commun 2018 21;15:17-20. Epub 2018 Feb 21.

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2018.02.004DOI Listing
June 2019

Severe pulmonary toxicity from immune checkpoint inhibitor treated successfully with intravenous immunoglobulin: Case report and review of the literature.

Respir Med Case Rep 2019 6;27:100834. Epub 2019 Apr 6.

Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmcr.2019.100834DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456450PMC
April 2019

Complete and Sustained Response of Brain Metastases to Programmed Death 1 Antibody Monotherapy in Treatment-naive Programmed Death Ligand 1-Positive Lung Cancer.

J Thorac Oncol 2019 02;14(2):e34-e36

Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.10.157DOI Listing
February 2019

Activity of Brigatinib in the Setting of Alectinib Resistance Mediated by ALK I1171S in ALK-Rearranged Lung Cancer.

J Thorac Oncol 2019 01 5;14(1):e1-e3. Epub 2018 Jul 5.

Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.06.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322846PMC
January 2019

EGFR Exon 20 Insertion Mutations Display Sensitivity to Hsp90 Inhibition in Preclinical Models and Lung Adenocarcinomas.

Clin Cancer Res 2018 12 28;24(24):6548-6555. Epub 2018 Aug 28.

Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-1541DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295229PMC
December 2018

Molecular Testing Turnaround Time in Non-Small-Cell Lung Cancer: Monitoring a Moving Target.

Clin Lung Cancer 2018 09 4;19(5):e589-e590. Epub 2018 May 4.

Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.04.005DOI Listing
September 2018

Lung Cancer with a High Tumor Mutational Burden.

N Engl J Med 2018 09;379(11):1093

Beth Israel Deaconess Medical Center, Boston, MA

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMc1808566
Publisher Site
http://dx.doi.org/10.1056/NEJMc1808566DOI Listing
September 2018

Targeting rearrangements in non-small cell lung cancer with crizotinib and other kinase inhibitors.

Transl Cancer Res 2018 Aug;7(Suppl 7):S779-S786

Department of Medicine, Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tcr.2018.08.11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186457PMC
August 2018

Safety and Efficacy of PD-1 Inhibitors Among HIV-Positive Patients With Non-Small Cell Lung Cancer.

J Thorac Oncol 2018 07 6;13(7):1037-1042. Epub 2018 Apr 6.

Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.03.031DOI Listing
July 2018

Updated Correlation of 22C3-PD-L1 ≥50% Expression with Driver Oncogene Mutations and Response to Pembrolizumab in the Kinase Inhibitor-Resistant Setting.

J Thorac Oncol 2018 05;13(5):e81-e83

Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.01.023DOI Listing
May 2018

Tumor biomarker testing in non-small-cell lung cancer: A decade of change.

Lung Cancer 2018 02 4;116:90-95. Epub 2018 Jan 4.

Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.01.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806129PMC
February 2018

De novo ERBB2 amplification causing intrinsic resistance to erlotinib in EGFR-L858R mutated TKI-naïve lung adenocarcinoma.

Lung Cancer 2017 12 24;114:108-110. Epub 2017 Aug 24.

Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.08.018DOI Listing
December 2017

Cases of ALK-Rearranged Lung Cancer with 5-Year Progression-Free Survival with Crizotinib as Initial Precision Therapy.

J Thorac Oncol 2017 11 10;12(11):e175-e177. Epub 2017 Jun 10.

Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.06.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5659921PMC
November 2017

Growing Pains: a Simulation-Based Curriculum for Improving the Transition to Hematology/Oncology Fellowship.

J Cancer Educ 2017 Sep;32(3):496-502

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13187-015-0974-1DOI Listing
September 2017

Molecular Testing Turnaround Time for Non-Small Cell Lung Cancer in Routine Clinical Practice Confirms Feasibility of CAP/IASLC/AMP Guideline Recommendations: A Single-center Analysis.

Clin Lung Cancer 2017 09 14;18(5):e349-e356. Epub 2017 Mar 14.

Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.03.001DOI Listing
September 2017

Beyond the Sandwich: From Feedback to Clinical Coaching for Residents as Teachers.

MedEdPORTAL 2017 09 18;13:10627. Epub 2017 Sep 18.

Associate Professor of Medicine, Johns Hopkins University School of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.15766/mep_2374-8265.10627DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354721PMC
September 2017

Moving more potent and less toxic options to the frontline in the management of advanced lung cancer.

J Thorac Dis 2017 Sep;9(9):2812-2818

Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, US.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2017.08.79DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708368PMC
September 2017

Clinical coaching: Evolving the apprenticeship model for modern housestaff.

Med Teach 2017 Jul 26;39(7):780-782. Epub 2016 Dec 26.

d Division of Infectious Diseases , Johns Hopkins University School of Medicine , Baltimore , MD , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0142159X.2016.1270425DOI Listing
July 2017

Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3-PD-L1 ≥50% Expression in Lung Adenocarcinoma.

J Thorac Oncol 2017 05 16;12(5):878-883. Epub 2017 Jan 16.

Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.12.026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403565PMC
May 2017

Mutations in TP53, PIK3CA, PTEN and other genes in EGFR mutated lung cancers: Correlation with clinical outcomes.

Lung Cancer 2017 04 25;106:17-21. Epub 2017 Jan 25.

Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.01.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351777PMC
April 2017

Compound Uncommon EGFR Mutations in a Patient with Advanced NSCLC and Durable Response to Sequential EGFR Targeted Therapies.

J Thorac Oncol 2017 04;12(4):e35-e36

Division of Hematology/Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.12.018DOI Listing
April 2017

Moving the mountain in advanced non-small-cell lung cancer: evolving immunotherapies for a dire disease.

Transl Cancer Res 2017 Feb;6(Suppl 1):S151-S157

Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tcr.2017.02.28DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319878PMC
February 2017

EGFR Testing in Advanced Non-Small-Cell Lung Cancer, A Mini-Review.

Clin Lung Cancer 2016 11 8;17(6):483-492. Epub 2016 Jun 8.

Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.05.016DOI Listing
November 2016

Rapidly fatal advanced -mutated lung cancers and the need for rapid tumor genotyping in clinical practice.

Cancer Treat Commun 2016 5;9:41-43. Epub 2016 Jul 5.

Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School; Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2016.07.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241076PMC
July 2016

Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches.

Ther Adv Respir Dis 2016 Apr 30;10(2):113-29. Epub 2015 Nov 30.

Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Shapiro 9, Boston, MA 02215, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1753465815617871DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933559PMC
April 2016

Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers.

Lung Cancer 2015 Apr 4;88(1):108-11. Epub 2015 Feb 4.

Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.01.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355240PMC
April 2015

Integrating palliative care in oncology: the oncologist as a primary palliative care provider.

Cancer J 2013 Sep-Oct;19(5):373-8

From the Sidney Kimmel Comprehensive Cancer Center at The Johns Hopkins Hospital, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0b013e3182a76b9cDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005332PMC
June 2014

Quiz page January 2014: Cachexia, urinary tract infection, nephromegaly, and kidney failure.

Am J Kidney Dis 2014 Jan;63(1):A18-21

Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD; Department of Nephrology, The Johns Hopkins University School of Medicine, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2013.07.027DOI Listing
January 2014

Targeting the immune system in the treatment of non-small-cell lung cancer.

Curr Treat Options Oncol 2013 Dec;14(4):580-94

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at The Johns Hopkins Hospital, Bunting-Blaustein Cancer Research Building 1, 1650 Orleans St., Room 186, Baltimore, MD, 21287, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-013-0250-8DOI Listing
December 2013